Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine

Ambriz Fernández, Raúl; Quintana González, Sandra; Martínez Murillo, Carlos; Domínguez García, Victoria; Rodríguez Moyado, Héctor; Collazo Jaloma, Juan.
Arch. med. res ; 27(1): 15-8, 1996. tab
Artículo en Inglés | LILACS | ID: lil-200284

Documentos relacionados

  1. Unresolved hemostasis issues in haemophilia.
  2. Advances toward gene therapy for hemophilia at the millennium.
  3. Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments.
  4. Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta study.
  5. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
  6. Haemophilia: factoring in new therapies.
  7. [Congenital hemophilia: a new treatment paradigm].
  8. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
  9. Shifting Paradigms and Arising Concerns in Severe Hemophilia A Treatment.
  10. An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma.